Startups
Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.
Summary
34
Industry
Total funding Amount
$2.9M
Fundraising History
-
Sep 01 '22 Seed$1.8M
-
Jan 01 '22 Seed$1.1M
Investors
-
i&i Biotech FundSeed